Endothelial nitric oxide synthase is essential for nitric oxide generation, L-type Ca2+ channel activation and survival in RBL-2H3 mast cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 3, 2010, Pages 372-385

  Suzuki, Yoshihiro ^a   Inoue, Toshio ^a   Ra, Chisei ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Ca2+; Endothelial NOS; Mast cell; Mitochondria; Nitric oxide; Survival

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; CASPASE 3; CASPASE 7; CYTOCHROME C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN E RECEPTOR; NITRIC OXIDE; SMALL INTERFERING RNA; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; GENE SILENCING; MAST CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CASPASES; CELL LINE; CELL SURVIVAL; CYTOCHROMES C; ENZYME INHIBITORS; MAST CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RECEPTORS, IGE; RNA, SMALL INTERFERING;

EID: 77249114733     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.11.003     Document Type: Article

References (54)

1. Parekh A.B., and Penner R. Store depletion and calcium influx. Physiol. Rev. 77 (1997) 901-930
2. Parekh A.B., and Putney Jr. J.W. Store-operated calcium channels. Physiol. Rev. 85 (2005) 757-810
3. 2+ signaling requirements. Biochem. J. 337 (1999) 153-169
4. Elliott A.C. Recent developments in non-excitable cell calcium entry. Cell Calcium 30 (2001) 73-93
5. Putney Jr. J.W., Broad L.M., Braun F.J., Lievremont J.P., and Bird G.S. Mechanisms of capacitative calcium entry. J. Cell Sci. 114 (2001) 2223-2229
6. 2+ stores in Ehrlich-ascites-tumour cells and in rat thymocytes. Biochem. J. 271 (1990) 535-540
7. 2+ influx in human neutrophils is secondary to the emptying of intracellular calcium stores. Biochem. J. 277 (1991) 73-79
8. 2+ stores. Biochem. Soc. Trans. 22 (1994) 809-813
9. Hoth M., and Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355 (1992) 353-356
10. 2+ stores. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6295-6299
11. 2+ entry: roles of Orai, Stim and TRP. Biochim. Biophys. Acta 1763 (2006) 1147-1160
12. Feske S. S. Calcium signalling in lymphocyte activation and disease. Nat. Rev., Immunol. 7 (2007) 690-702
13. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
14. Baba Y., Nishida K., Fujii Y., Hirano T., Hikida M., and Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 9 (2008) 81-88
15. Vig M., DeHaven W.I., Bird G.S., Billingsley J.M., Wang H., Rao P.E., Hutchings A.B., Jouvin M.H., Putney J.W., and Kinet J.P. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat. Immunol. 9 (2008) 89-96
16. Vig M., and Kinet J.P. Calcium signaling in immune cells. Nat. Immunol. 10 (2009) 21-27
17. 2+ entry mechanism. J. Biol. Chem. 276 (2001) 14814-14820
18. Bradding P., Okayama Y., Kambe N., and Saito H. Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J. Leukoc. Biol. 73 (2003) 614-620
19. Kahr H., Schindl R., Fritsch R., Heinze B., Hofbauer M., Hack M.E., Mörtelmaier M.A., Groschner K., Peng J.B., Takanaga H., Hediger M.A., and Romanin C. CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells. J. Physiol. 557 (2004) 121-132
20. Grafton G., Stokes L., Toellner K.M., and Gordon J. A non-voltage-gated calcium channel with L-type characteristics activated by B cell receptor ligation. Biochem. Pharmacol. 66 (2003) 2001-2009
21. Akha A.A.S., Willmott N.J., Brickley K., Dolphin A.C., Galione A., and Hunt S.V. Anti-Ig-induced calcium influx in rat B lymphocytes mediated by cGMP through a dhydropyridine-sensitive channel. J. Biol. Chem. 271 (1996) 7297-7300
22. Poggi A., Rubartelli A., and Zocchi M.R. Involvement of dihydropyridine- sensitive calcium channels in human dendritic cell function. Competition by HIV-1 Tat. J. Biol. Chem. 273 (1988) 7205-7209
23. v1.2 is involved in dendritic cell major histocompatibility complex class II surface expression. J. Biol. Chem. 283 (2008) 34913-34922
24. Zocchi M.R., Rubartelli A., Morgavi P., and Poggi A. HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels. J. Immunol. 161 (1998) 2938-2943
25. 2+ release from intracellular stores in neutrophils. J. Biol. Chem. 267 (1992) 1443-1448
26. Kotturi M.F., Carlow D.A., Lee J.C., Ziltener H.J., and Jefferies W.A. Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes. J. Biol. Chem. 278 (2003) 46949-46960
27. 2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits. J. Biol. Chem. 279 (2004) 19566-19573
28. Savignac M., Badou A., Moreau M., Leclerc M.C., Guéry J.C., Paulet P., Druet P., Ragab-Thomas J., and Pelletier L. Protein kinase C-mediated calcium entry dependent upon dihydropyridine sensitive channels: a T cell receptor-coupled signaling pathway involved in IL-4 synthesis. FASEB J. 15 (2001) 1577-1579
29. Savignac M., Gomes B., Gallard A., Narbonnet S., Moreau M., Leclerc C., Paulet P., Mariamé B., Druet P., Saoudi A., Fournié G.J., Guéry J.C., and Pelletier L. Dihydropyridine receptors are selective markers of Th2 cells and can be targeted to prevent Th2-dependent immunopathological disorders. J. Immunol. 172 (2004) 5206-5212
30. 2 channels. Mol. Immunol. 46 (2009) 1267-1277
31. 2+ channel protects mast cells against activation-induced cell death by preventing mitochondrial integrity disruption. Mol. Immunol. 46 (2009) 2370-2380
32. Inoue T., Suzuki Y., Yoshimaru T., and Ra C. Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway. J. Leukoc. Biol. 83 (2008) 1218-1229
33. Suzuki Y., Yoshimaru T., Matsui T., Inoue T., Niide O., Nunomura S., and Ra C. Fce{open}RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals. J. Immunol. 171 (2003) 6119-6127
34. Werner E.R., and Werner-Felmayer G. Biopterin analogues: novel nitric oxide synthase inhibitors with immunosuppressive action. Curr. Drug Metab. 3 (2002) 119-121
35. Werner E.R., Gorren A.C., Heller R., Werner-Felmayer G., and Mayer B. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp. Biol. Med. (Maywood) 228 (2003) 1291-1302
36. Suzuki Y., Yoshimaru T., Inoue T., Nunomura S., and Ra C. The high-affinity immunoglobulin E receptor (Fce{open}RI) regulates mitochondrial calcium uptake and a dihydropyridine receptor-mediated calcium influx in mast cells: role of the Fce{open}RIβ chain immunoreceptor tyrosine-based activation motif. Biochem. Pharmacol. 75 (2008) 1492-1503
37. Gallis B., Corthals G.L., Goodlett D.R., Ueba H., Kim F., Presnell S.R., Figeys D., Harrison D.G., Berk B.C., Aebersold R., and Corson M.A. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J. Biol. Chem. 274 (1999) 30101-30108
38. McCabe T.J., Fulton D., Roman L.J., and Sessa W.C. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J. Biol. Chem. 275 (2000) 6123-6128
39. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
40. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
41. Martin S., Pombo I., Poncet P., David B., Arock M., and Blank U. Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int. Arch. Allergy Immunol. 123 (2001) 249-258
42. Suzuki Y., Inoue T., Yoshimaru T., and Ra C. Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition. Biochim. Biophys. Acta 1783 (2008) 924-934
43. Eastmond N.C., Banks E.M., and Coleman J.W. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159 (1997) 1444-1450
44. Davis B.J., Flanagan B.F., Gilfillan A.M., Metcalfe D.D., and Coleman J.W. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J. Immunol. 173 (2004) 6914-6920
45. Sekar Y., Moon T.C., Muñoz S., and Befus A.D. Role of nitric oxide in mast cells: controversies, current knowledge, and future applications. Immunol. Res. 33 (2005) 223-229
46. Bidri M., Ktorza S., Vouldoukis I I., Le Goff L., Debré P., Guillosson J.J., and Arock M. Nitric oxide pathway is induced by Fce{open}RI and up-regulated by stem cell factor in mouse mast cells. Eur. J. Immunol. 27 (1997) 2907-2913
47. Bidri M., Féger F., Varadaradjalou S., Ben Hamouda N., Guillosson J.J., and Arock M. Mast cells as a source and target for nitric oxide. Int. Immunopharmacol. 1 (2001) 1543-1558
48. Gilchrist M., Savoie M., Nohara O., Wills F.L., Wallace J.L., and Befus A.D. AD, Nitric oxide synthase and nitric oxide production in vivo-derived mast cells. J. Leukoc. Biol 71 (2002) 618-624
49. Gilchrist M., McCauley S.D., and Befus A.D. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 104 (2004) 462-469
50. Swindle E.J., Metcalfe D.D., and Coleman J.W. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J. Biol. Chem. 279 (2004) 48751-48759
51. Martelli A.M., Faenza I., Billi A.M., Manzoli L., Evangelisti C., Falà F., and Cocco L. Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?. Cell. Signal. 18 (2006) 1101-1107
52. Dimmeler S., and Zeiher A.M. Nitric oxide-an endothelial cell survival factor. Cell Death Differ. 6 (1999) 964-968
53. Parcellier A., Tintignac L.A., Zhuravleva E., and Hemmings B.A. PKB and the mitochondria: AKTing on apoptosis. Cell. Signal. 20 (2007) 21-30
54. Furuke K., Burd P.R., Horvath-Arcidiacono J.A., Hori K., Mostowski H., and Bloom E.T. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-α. J. Immunol. 163 (1999) 1473-14780